Craig Gracey Sells 2,084 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,084 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $20.00, for a total value of $41,680.00. Following the transaction, the chief accounting officer directly owned 2,941 shares in the company, valued at $58,820. This trade represents a 41.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Craig Gracey also recently made the following trade(s):

• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $21.00, for a total value of $43,743.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $19.01, for a total value of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $18.00, for a total transaction of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total transaction of $120,093.48.

Omada Health Trading Up 1.3%

NASDAQ OMDA traded up $0.28 during trading on Tuesday, hitting $21.95. The company had a trading volume of 853,685 shares, compared to its average volume of 1,070,637. The company’s fifty day moving average is $16.83 and its 200-day moving average is $14.93. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92. The company has a market cap of $1.30 billion and a price-to-earnings ratio of -81.30.

Omada Health (NASDAQ:OMDA) last announced its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The firm had revenue of $78.05 million for the quarter. As a group, equities analysts anticipate that Omada Health, Inc. will post -0.01 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have weighed in on OMDA. Citizens Jmp lifted their price objective on Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a research report on Friday, May 8th. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday. Canaccord Genuity Group set a $24.00 target price on Omada Health in a research note on Friday, May 8th. Barclays lifted their price target on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research report on Friday, May 8th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $22.91.

Hedge Funds Weigh In On Omada Health

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Raymond James Financial Inc. purchased a new position in shares of Omada Health during the second quarter valued at approximately $32,000. Quarry LP bought a new stake in shares of Omada Health in the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. purchased a new stake in shares of Omada Health in the 4th quarter worth approximately $32,000. Inlight Wealth Management LLC bought a new position in Omada Health during the 4th quarter valued at approximately $45,000. Finally, JPMorgan Chase & Co. bought a new position in Omada Health during the 3rd quarter valued at approximately $82,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.